+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Sleep-Wake Disorder Market 2019-2025

  • PDF Icon


  • February 2020
  • Region: United States
  • Orion Market Research Private Limited
  • ID: 5013510
US Sleep-Wake Disorder Market Size, Share & Trends Analysis Report by Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Disorders, and Others) and by Treatment (Therapies, Drugs, and Treatment), and Forecast 2019-2025.

The US sleep-wake disorder market is estimated to grow at a CAGR of 6.0% during the forecast period. The growth of the sleep-wake disorder market in the US is attributed to the presenvce of well-established healthcare infrastructure, rise in awareness among people, and an increase in the prevalence of sleep disorders. As per the World Bank, the aging population of US was around 52.3 million. The geriatric population is more prone to sleep-wake disorders. In addition, the presence of major market players, including ResMed Inc., Neurocrine Biosciences, Inc., and others further supports the growth of sleep-wake disorder market in the region during the forecast period.

The market is segmented on the basis of type and treatment. Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest market share during the forecast period. On the basis of treatment, the market is divide into therapies, drugs, and devices. The sleep-wake disorder devices segment is estimated to hold the largest market share during the forecast period, followed by medications.

Some of the players operating in the US sleep-wake disorder market include Acorda Therapeutics Inc., Merck & Co. Inc., Pfizer Inc., Somnarus Inc., ResMed Inc., and others. In January 2018, Resmed introduced Mobi which is a portable oxygen concentrator (POC). In May 2017, Resmed launched AirTouch F20 full face mask with UltraSoft memory for comfortable therapy of the patients. Further, in June 2017, Somnarus, Inc. introduced a new disposable, wearable patch for the effective detection of sleep apnea and other related diseases. The development of novel drugs for the treatment of sleep apnea enables the company to generate revenue and growth of the company.

Research Methodology

The market study of the US sleep-wake disorder market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for hospitals, sleep disorder device manufacturers, drug manufacturers, physicians, senior care centers, nursing centers, research organizations, investment companies, government organizations, regulatory authorities, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis of the market size and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. US Sleep-Wake Disorder Market Research and Analysis by Type
2. US Sleep-Wake Disorder Market Research and Analysis by Treatment

The Report Covers
  • Comprehensive research methodology of the US Sleep-Wake Disorder Market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the US Sleep-Wake Disorder Market.
  • Insights about market determinants which are stimulating the US Sleep-Wake Disorder Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. US Sleep-Wake Disorder Market by Type
5.1.1. Insomnia
5.1.2. Hypersomnia
5.1.3. Circadian Rhythm Disorders
5.1.4. Others
5.2. US Sleep-Wake Disorder Market by Treatment
5.2.1. Therapies
5.2.2. Drugs
5.2.3. Devices
6. Company Profiles
6.1. Aeroflow, Inc.
6.2. Arena Pharmaceuticals, Inc.
6.3. Acorda Therapeutics, Inc.
6.4. Merck & Co., Inc.
6.5. Natus Medical Inc.
6.6. Pfizer Inc.
6.7. ResMed Inc.
6.8. RespireRx Pharmaceuticals Inc.
6.9. Somnarus Inc.
6.10. Somnetics International Inc.
6.11. TotalCare eHealth

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Aeroflow, Inc.
  • Arena Pharmaceuticals, Inc.
  • Acorda Therapeutics, Inc.
  • Merck & Co., Inc.
  • Natus Medical Inc.
  • Pfizer Inc.
  • ResMed Inc.
  • RespireRx Pharmaceuticals Inc.
  • Somnarus Inc.
  • Somnetics International Inc.
  • TotalCare eHealth